摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(邻甲苯基氧基)苯胺 | 116289-57-7

中文名称
3-(邻甲苯基氧基)苯胺
中文别名
——
英文名称
3-(o-tolyloxy)aniline
英文别名
3-o-Tolyloxy-anilin;3-(2-Methylphenoxy)aniline
3-(邻甲苯基氧基)苯胺化学式
CAS
116289-57-7
化学式
C13H13NO
mdl
——
分子量
199.252
InChiKey
UKGBZDIJGCQUJD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.08
  • 拓扑面积:
    35.2
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    3-(邻甲苯基氧基)苯胺吡啶 作用下, 以 1,2-二氯乙烷 为溶剂, 生成 2,2,2-trifluoro-N-[3-(2-methylphenoxy)phenyl]-N-(pyrimidin-5-ylmethyl)ethane-sulfonamide
    参考文献:
    名称:
    Pyrimidine methyl anilines: selective potentiators for the metabotropic glutamate 2 receptor
    摘要:
    Pyrimidine methyl anilines as potent and selective mGlu2 potentiators are described. Findings from the structure-activity-relationship investigations are discussed. (C) 2004 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2004.07.079
  • 作为产物:
    参考文献:
    名称:
    Ikawa, Yakugaku Zasshi/Journal of the Pharmaceutical Society of Japan, 1955, vol. 75, p. 457,459
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Discovery of a Functional Covalent Ligand Targeting an Intrinsically Disordered Cysteine within MYC
    作者:Lydia Boike、Alexander G. Cioffi、Felix C. Majewski、Jennifer Co、Nathaniel J. Henning、Michael D. Jones、Gang Liu、Jeffrey M. McKenna、John A. Tallarico、Markus Schirle、Daniel K. Nomura
    DOI:10.1016/j.chembiol.2020.09.001
    日期:2021.1
    remained intractable to direct targeting because much of MYC is intrinsically disordered. Here, we have performed a cysteine-reactive covalent ligand screen to identify compounds that could disrupt the binding of MYC to its DNA consensus sequence in vitro and also impair MYC transcriptional activity in situ in cells. We have identified a covalent ligand, EN4, that targets cysteine 171 of MYC within a predicted
    MYC 是大多数人类癌症的主要致癌转录驱动因子,由于 MYC 的大部分本质上是无序的,因此直接靶向仍然难以处理。在这里,我们进行了半胱酸反应性共价配体筛选,以鉴定可能在体外破坏 MYC 与其 DNA 共有序列结合并损害 MYC原位转录活性的化合物在细胞中。我们已经确定了一种共价配体 EN4,它在预测的蛋白质固有无序区域内靶向 MYC 的半胱酸 171。我们表明 EN4 直接靶向细胞中的 MYC,降低 MYC 和 MAX 热稳定性,抑制 MYC 转录活性,下调多个 MYC 转录靶标,并损害肿瘤发生。我们还展示了 EN4 的初始结构-活性关系,并确定了显示增强效力的化合物。总体而言,我们在 MYC 的内在无序区域内确定了一个独特的可配位位点,导致 MYC 转录活性的抑制。
  • EPOXY COMPOUND AND MANUFACTURING METHOD THEREOF
    申请人:Ono Koutaro
    公开号:US20110040111A1
    公开(公告)日:2011-02-17
    A novel epoxy compound represented by the following formula and a method for producing the same are provided: wherein R 1 and R 2 are members selected from the group consisting of hydrogen, aliphatic hydrocarbon group having 1 to 4 carbon atoms, alicyclic hydrocarbon group having 3 to 6 carbon atoms, aromatic hydrocarbon group having 6 to 10 carbon atoms, halogen atom, ether group, ester group, acyl group and nitro group, n is an integer of 1 to 4, and m is an integer of 1 to 5.
    提供了一种由以下式表示的新型环氧化合物及其制备方法:其中R1和R2是从氢、具有1至4个碳原子的脂肪烃基、具有3至6个碳原子的脂环烃基、具有6至10个碳原子的芳香烃基、卤原子、醚基、酯基、酰基和硝基组成的群体中选择的成员,n是1至4的整数,m是1至5的整数。
  • 1H,3H-pyrrol[1,2-c]thiazole derivatives and pharmaceutical compositions
    申请人:Rhone-Poulenc Sante
    公开号:US04783472A1
    公开(公告)日:1988-11-08
    A compound of the general formula I; ##STR1## in which R is hydrogen or a halogen or an alkyl, alkyloxy, alkylthio, trifluoromethyl, amino, alkylamino, dialkylamino, hydroxy, cyano, carboxy, alkylsulphinyl, alkylsulphonyl, sulphamido, alkylsulphamido, dialkylsulphamido, carbamoyl, alkylcarbamoyl, dialkylcarbamoyl, phenylcarbamoyl, diphenylcarbamoyl, pyridylcarbamoyl, dipyridylcarbamoyl, benzyl, alkylcarbonyl, benzoyl, alkyloxycarbonyl, phenoxycarbonyl, alkylcarbonyloxy, benzoyloxy, alkylcarbonylamino, benzamido, phenyl, phenoxy or phenylthio group, X is oxygen or sulphur or an imino, alkylimino, phenylimino, benzylimino, sulphinyl, sulphonyl, carbonyl, carbonylmethylene, methylenecarbonyl, carbonylvinylene or vinylenecarbonyl group, or X represents a valency bond or a straight-chain alkylene group containing 1 to 4 carbon atoms and Ar is a phenyl, naphthyl, pyridyl, quinolinyl, isoquinolinyl, thienyl, benzothienyl, thieno[3,2-b]thien-2-yl or thieno[2,3-b]thien-2-yl group, it being possible for the group Ar to be unsubstituted or substituted with one or more halogen or alkyl, alkyloxy, alkylthio, trifluoromethyl, amino, alkylamino, dialkylamino, hydroxy, cyano, carboxy, alkylsulphinyl, alkylsulphonyl, sulphamido, alkylsulphamido, dialkylsulphamido, carbamoyl, alkylcarbamoyl, dialkylcarbamoyl, phenylcarbamoyl, diphenylcarbamoyl, pyridylcarbamoyl, dipyridylcarbamoyl, benzyl, alkylcarbonyl, benzoyl, alkyloxycarbonyl, phenoxycarbonyl, alkylcarbonyloxy, benzoyloxy, alkylcarbonylamino or benzamido group; each alkyl moiety containing 1 to 4 straight- or branched-chain carbon atoms; the compound being in separate enantiomeric form or mixtures thereof or a pharmaceutically acceptable salt thereof is useful in the treatment of all the pathological conditions in which PAF-acether may be directly or indirectly implicated.
    通式为I的化合物;##STR1## 其中R是氢或卤素或烷基,烷氧基,烷基,三甲基,基,烷基基,二烷基基,羟基,基,羧基,烷基磺酰基,烷基磺酰基,磺酰胺基,烷基磺酰胺基,二烷基磺酰胺基,基甲酰基,烷基甲酰基,二烷基甲酰基,苯基甲酰基,二苯基甲酰基,吡啶甲酰基,二吡啶甲酰基,苄基,烷基羰基,苯甲酰基,烷氧羰酰基,苯氧羰酰基,烷基羰酰氧基,苯甲酰氧基,烷基羰基基,苯甲酰胺基,苯基,苯氧基或苯基,X是氧或亚胺基,烷基亚胺基,苯基亚胺基,苄基亚胺基,磺酰基,磺酰基,羰基,羰基亚甲基,羰基乙烯基乙烯基羰基基团,或X表示价键或含有1到4个碳原子的直链烷基基团,Ar是苯基,基,吡啶基,喹啉基,异喹啉基,噻吩基,苯并噻吩基,噻吩[3,2-b]噻吩-2-基或噻吩[2,3-b]噻吩-2-基团,其中Ar基团可能是未取代或取代一个或多个卤素或烷基,烷氧基,烷基,三甲基,基,烷基基,二烷基基,羟基,基,羧基,烷基磺酰基,烷基磺酰基,磺酰胺基,烷基磺酰胺基,二烷基磺酰胺基,基甲酰基,烷基甲酰基,二烷基甲酰基,苯基甲酰基,二苯基甲酰基,吡啶甲酰基,二吡啶甲酰基,苄基,烷基羰基,苯甲酰基,烷氧羰酰基,苯氧羰酰基,烷基羰酰氧基,苯甲酰氧基,烷基羰基基,苯甲酰胺基或苯基基基团;每个烷基含有1到4个直链或支链碳原子;该化合物以分离的对映异构体形式或其混合物或其药学上可接受的盐形式在PAF-acether可能直接或间接涉及的所有病理情况的治疗中有用。
  • Orthogonal Cu- and Pd-Based Catalyst Systems for the O- and N-Arylation of Aminophenols
    作者:Debabrata Maiti、Stephen L. Buchwald
    DOI:10.1021/ja9081815
    日期:2009.12.2
    O- or N-arylated aminophenol products constitute a common structural motif in various potentially useful therapeutic agents and/or drug candidates. We have developed a complementary set of Cu- and Pd-based catalyst systems for the selective O- and N-arylation of unprotected aminophenols using aryl halides. Selective O-arylation of 3- and 4-aminophenols is achieved with copper-catalyzed methods employing picolinic acid or CyDMEDA, trans-N,N'-dimethyl-1,2-cyclohexanediamine, respectively, as the ligand. The selective formation of N-arylated products of 3- and 4-aminophenols can be obtained with BrettPhos precatalyst, a biarylmonophosphine-based palladium catalyst. 2-Aminophenol can be selectively N-arylated with CuI, although no system for the selective O-arylation could be found. Coupling partners with diverse electronic properties and a variety of functional groups can be selectively transformed under these conditions.
  • US4783472A
    申请人:——
    公开号:US4783472A
    公开(公告)日:1988-11-08
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫